Product Program year 2022 Source: CMS Open Payments

Nityr

Drug Gastrointestinal

NDC 70709-000-60

Open in the dashboard

General payments

$43,629

51 payments

Research payments

$0

0 payments

Through program year 2022, $43,629 in general payments and $0 in research payments were reported against Nityr (Gastrointestinal).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2022 General $22,695 28
2021 General $20,935 23

Breakdown

Who paid General payments · program years 2021–2022
  1. Cycle Pharmaceuticals Inc $43,629 51 payments
Top recipients General payments · program year 2022
  1. Benjamin Greenberg Neurology · Dallas, TX $1,995 9% · 1 payment
  2. John Anderson Allergy & Immunology · Homewood, AL $1,851 8% · 1 payment
  3. Lawrence Schwartz Allergy & Immunology · Somers Point, NJ $1,545 7% · 2 payments
  4. Jonathan Santoro Neurology with Special Qualifications in Child Neurology · Palo Alto, CA $1,500 7% · 1 payment
  5. Michael Manning Allergy & Immunology · Scottsdale, AZ $1,438 6% · 1 payment

The top 5 of 26 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Allergy & Immunology $9,122 40% · 8 practitioners
  2. Neurology Psychiatry & Neurology $2,769 12% · 2 practitioners
  3. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $2,630 12% · 2 practitioners
  4. Allergy Allergy & Immunology $1,870 8% · 2 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $1,683 7% · 3 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Texas $3,220 14% · 3 recipients
  2. Alabama $2,981 13% · 2 recipients
  3. New Jersey $2,675 12% · 2 recipients
  4. California $2,525 11% · 3 recipients
  5. Michigan $2,318 10% · 3 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

51 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record